LCOR Reverses Immune-Checkpoint Inhibitors Therapy Resistance Out of IFN Constraint in Triple-Negative Breast Cancer

Detalles Bibliográficos
Autores principales: Zhou, Jialin, Feng, Chun, Huang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326162/
https://www.ncbi.nlm.nih.gov/pubmed/35912168
http://dx.doi.org/10.3389/fonc.2022.911572
_version_ 1784757218646687744
author Zhou, Jialin
Feng, Chun
Huang, Kai
author_facet Zhou, Jialin
Feng, Chun
Huang, Kai
author_sort Zhou, Jialin
collection PubMed
description
format Online
Article
Text
id pubmed-9326162
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93261622022-07-28 LCOR Reverses Immune-Checkpoint Inhibitors Therapy Resistance Out of IFN Constraint in Triple-Negative Breast Cancer Zhou, Jialin Feng, Chun Huang, Kai Front Oncol Oncology Frontiers Media S.A. 2022-07-13 /pmc/articles/PMC9326162/ /pubmed/35912168 http://dx.doi.org/10.3389/fonc.2022.911572 Text en Copyright © 2022 Zhou, Feng and Huang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhou, Jialin
Feng, Chun
Huang, Kai
LCOR Reverses Immune-Checkpoint Inhibitors Therapy Resistance Out of IFN Constraint in Triple-Negative Breast Cancer
title LCOR Reverses Immune-Checkpoint Inhibitors Therapy Resistance Out of IFN Constraint in Triple-Negative Breast Cancer
title_full LCOR Reverses Immune-Checkpoint Inhibitors Therapy Resistance Out of IFN Constraint in Triple-Negative Breast Cancer
title_fullStr LCOR Reverses Immune-Checkpoint Inhibitors Therapy Resistance Out of IFN Constraint in Triple-Negative Breast Cancer
title_full_unstemmed LCOR Reverses Immune-Checkpoint Inhibitors Therapy Resistance Out of IFN Constraint in Triple-Negative Breast Cancer
title_short LCOR Reverses Immune-Checkpoint Inhibitors Therapy Resistance Out of IFN Constraint in Triple-Negative Breast Cancer
title_sort lcor reverses immune-checkpoint inhibitors therapy resistance out of ifn constraint in triple-negative breast cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326162/
https://www.ncbi.nlm.nih.gov/pubmed/35912168
http://dx.doi.org/10.3389/fonc.2022.911572
work_keys_str_mv AT zhoujialin lcorreversesimmunecheckpointinhibitorstherapyresistanceoutofifnconstraintintriplenegativebreastcancer
AT fengchun lcorreversesimmunecheckpointinhibitorstherapyresistanceoutofifnconstraintintriplenegativebreastcancer
AT huangkai lcorreversesimmunecheckpointinhibitorstherapyresistanceoutofifnconstraintintriplenegativebreastcancer

Ejemplares similares